Although NFkappaB binding activity is induced during liver regeneration after partial hepatectomy, the physiological consequence of this induction is unknown. We have assessed the role of NFkappaB during liver regeneration by delivering to the liver a superrepressor of NFkappaB activity using an adenoviral vector expressing a mutated form of IkappaBalpha. This adenovirus (Ad5IkappaB) was almost exclusively expressed in the liver and inhibited NFkappaB DNA binding activity and transcriptional activity in cultured cells as well as in the liver in vivo. After partial hepatectomy, infection with Ad5IkappaB, but not a control adenovirus (Ad5LacZ), resulted in the induction of massive apoptosis and hepatocytes as demonstrated by histological staining and TUNEL analysis. In addition, infection with Ad5IkappaB but not Ad5LacZ decreased the mitotic index after partial hepatectomy. These two phenomena, increased apoptosis and failure to progress through the cell cycle, were associated with liver dysfunction in animals infected with the Ad5IkappaB but not Ad5LacZ, as demonstrated by elevated serum bilirubin and ammonia levels. Thus, the induction of NFkappaB during liver regeneration after partial hepatectomy appears to be a required event to prevent apoptosis and to allow for normal cell cycle progression.
Introduction
Hepatocytes of normal adult liver divide infrequently. However, immediately after partial hepatectomy (PH), 1 there is a sequential and regulated series of events as the quiescent hepatocytes progress in the cell cycle from G-0 to G-1 (1, 2) . The earliest signals after PH include increased JNK and ERK activity (3) (4) (5) , increased NF B binding activity (6) (7) (8) , and increased STAT-3 DNA binding activity (9, 10) . The hepatocytes progress through the cell cycle and proliferation continues until the liver mass is restored.
NF B is a ubiquitous transcription factor that is activated by a variety of cytokines and mitogens (11) and is thought to be a key regulator of genes involved in inflammation, responses to infection, and stress. The targets for transcriptional activation of NF B include the genes for cytokines, acute phase response proteins, immunoglobulins, and cell adhesion molecules. Classic NF B is a heterodimer of p50 (NF B-1) and p65 (Rel-A), but proteins that constitute the NF B family form a variety of homodimers and heterodimers (12) . NF B is retained in an inactive form in the cytoplasm through association with one of the I B inhibitory proteins, including I B ␣ or I B ␤ (13) . After cellular stimulation, the phosphorylation, ubiquination, and subsequent proteolysis of I B ␣ in proteosomes enables NF B to translocate into the nucleus (14) (15) (16) , where it regulates the transcription of NF B-responsive genes by interacting with B binding sites (17, 18) .
A superrepressor form of I B ␣ contains serine-to-alanine mutations at amino acids 32 and 36, which inhibit signalinduced phosphorylation and subsequent proteosome-mediated degradation of I B ␣ . This I B superrepressor has been used to demonstrate that inhibition of NF B induces apoptosis through a variety of cancer therapeutic agents and TNF-␣ (19, 20) . Further support for an antiapoptotic role of NF B was suggested by the embryonic death of NF B p65 knockout mice from extensive apoptosis in the liver (21).
Thus NF B is believed to be a pivotal transcription factor in liver regeneration as well as in liver development. However, the pathophysiological sequelae of induced NF B DNA binding activity during liver regeneration is unknown. In this study, we assess the role of NF B in liver regeneration after PH by expressing the I B superrepressor in the adult rat liver in vivo.
Methods

Construction of recombinant adenovirus Ad5I B.
The recombinant replication-deficient adenovirus Ad5I B was constructed by the methods of Graham et al. (22, 23) . In brief, plasmid pRc/CMV-I B ␣ S32A/S36A (generous gift of Dr. Joseph Didonato, University of San Diego, San Diego, CA), which contains a hemagglutinin (HA)-tagged human superrepressor of NF B, was subcloned into the XbaI site of the pACCMV.PLPASR ( ϩ ) plasmid to construct the plasmid pACCMV/ I B, in which I B is driven by the CMV promoter/enhancer. The plasmid DNA was prepared by the alkaline lysis method and purified by CsCl-ethidium bromide density gradient centrifugation. The recombinant adenovirus I B was then constructed by cotransfection of the 293 embryonic human kidney cell line with the pACCMV/I B plasmid plus the purified fragment of ClaI-digested DNA from E1-deleted adenovirus type 5 (Ad5). The presence of the mutant I B sequence packaged into the recombinant Ad5 virus (Ad5I B) was confirmed by PCR and by Western blotting, as described below. Ad5I B was grown in 293 cells and purified by banding twice on CsCl gradients. Viral titers were determined by optical densitometry (particles per milliliter) and by plaque assay, and recombinant virus was then stored in 10% (vol/vol) glycerol at Ϫ 20 Њ C. Ad5LacZ, which contains Escherichia coli ␤ -galactosidase gene, was also grown and purified as described above and used as a control virus.
Cell culture, viral infection, transfection, and reporter gene assay. Rat-1 fibroblasts were grown on 6-well culture plates (Costar Corp., Cambridge, MA) in MEM plus 10% FBS. When the fibroblasts reached 50-60% confluency, the medium was changed to MEM containing 2% FBS, and Ad5I B or Ad5LacZ viral stock solutions were added to the medium at various multiplicities of infection (moi). After 24 h in some experiments, cells (70-80% confluent) were transfected with 0.5 g of NF B-Luc (a reporter plasmid containing one copy of an NF B binding site [24]), with or without 0.1 g of a p65 expression plasmid (a plasmid containing the NF B p65 driven by a CMV promoter [25] ) using Lipofectin reagent (GIBCO BRL, Gaithersburg, MD) per plate, and incubated in serum-free MEM. 24 h after transfection, cells were washed once with PBS, and medium was replaced with MEM containing 10% FBS. After an additional 24 h, recombinant human TNF-␣ (50 ng/ml) was added to the media in some wells. After a 5-h incubation, cellular extracts were prepared using enhanced luciferase assay reagents (Analytical Luminescence, San Diego, CA). Luciferase activity was measured on a Monolight 2010 for 15 s, and results were normalized for protein concentration. For NF B electrophoretic mobility shifts assay, the transfected cells were treated with TNF-␣ (50 ng/ml) for 1 h and nuclear extracts were obtained as described below. For Western blot analysis, cells were collected after a 24-h infection with adenovirus, and whole cell extracts were prepared as described below.
Western blot analysis. Rat-1 fibroblasts infected with Ad5IkB or Ad5LacZ and samples of liver, spleen, kidney, lung, and heart were homogenized in lysis buffer (10 mM Hepes, pH 7.9, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 0.5% NP-40, and 25% glycerol) with protease inhibitors (4) at 4 Њ C, followed by rotating the tubes for 30 min at 4 Њ C. After centrifugation, cleared tissue lysates were collected and stored at Ϫ 80 Њ C for later analysis. Lysate containing 30 g of protein was separated by electrophoresis on 10% acrylamide SDS gels and transferred to PVDF membranes as described previously (3) . Equal loading was confirmed by Ponceau S staining. I B ␣ was detected using rabbit anti-I B ␣ antibody (Santa Cruz Biotechnology, Santa Cruz, CA). Blots were blocked in blocking buffer (5% nonfat dry milk in PBST) for 1 h, incubated overnight at 4 Њ C in primary antibody, diluted 1:1,000 in blocking buffer, and then 1 h with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (Santa Cruz Biotechnology), diluted 1:1,000 in blocking buffer. Proteins were detected with ECL detection reagents (Amersham Corp., Arlington Heights, IL).
Nuclear extract preparation and electrophoretic mobility shift assay. Nuclear proteins were prepared from Rat-1 fibroblasts and the liver tissues using previously described methods (26) . Protein-DNA binding reactions were carried out for 20 min on ice, using 5 g nuclear extract, 10 pg of 32 P-labeled DNA probes for the NF B consensus binding site (27) , with or without 1 ng (100 ϫ ) unlabeled competitor probe. Complexes were separated by electrophoresis on nondenaturing 5% acrylamide gels and assayed by autoradiography and PhosphorImager analysis (Molecular Dynamics, Sunnyvale, CA). Antibodies against p65 or p50 subunit of the NF B complex (Santa Cruz Biotechnology) were used for super-shift assays.
Adenoviral infection, PH, and BrdU labeling. Ad5IkB or Ad5LacZ was stored in 10% glycerol and was then twice dialyzed against a solution containing 10 mM Tris, pH 8.0, 1 mM MgCl 2 , and 140 mM NaCl, for 2 h just before use. The viral solution containing 10 10 plaque forming units (pfu) (0.5 ml) was injected into male Sprague-Dawley rats (220-240 g) via tail vein. 24 h after viral injection, two-thirds PH was performed according to the methods of Higgins and Anderson (28) under pentobarbital anesthesia. 11, 23, or 47 h after PH, animals were injected with BrdU (100 mg/kg; Sigma Chemical Co., St. Louis, MO) and killed 1 h later ( n ϭ 3-5 per time point). Blood samples were collected by puncture of abdominal aorta and serum was stored at Ϫ 80 Њ C until analysis. Samples of the liver were snap-frozen in liquid nitrogen or were fixed in 10% buffered formalin for subsequent histological analysis. Samples of spleen, kidney, lung, and heart were also collected and snap-frozen in liquid nitrogen. To assess BrdU staining at 0 h, some animals ( n ϭ 3) were injected with BrdU (100 mg/kg) at 23 h after viral injection and killed 1 h later. Control animals ( n ϭ 3) were injected with the same amount of saline, underwent two-thirds PH 24 h later, and then were killed 1 h later.
Histology and immunohistochemistry. Paraffin-embedded tissues were sectioned and stained with hematoxylin and eosin (H&E). For immunohistochemistry, sections were deparaffinized by four 5-min incubations in xylene, followed by several changes of ethanol (100, 95, 70, and 30%) and rehydration in dH 2 O. DAKO Envision system™ (DAKO Corp., Carpinteria, CA) was used for BrdU and HA peptide epitope immunostaining. For BrdU assay, sections were incubated in 4 N HCl for 20 min at 37 Њ C and washed several times with dH 2 O and 1 ϫ PBS-Tween 20 (PBST; Sigma Chemical Co.). After blocking of endogenous peroxidase with peroxidase blocking agent, sections were incubated with mouse monoclonal anti-BrdU antibody (1:200 in PBS containing 5% BSA; Sigma Chemical Co.) for 10 min at 25 Њ C. After two 3-min washes in PBST, sections were incubated with labeled polymer (peroxidase-labeled polymer conjugated to goat anti-rabbit and goat anti-mouse immunoglobulins) for 10 min at 25 Њ C. Sections were then washed twice with PBST, incubated with 3,3-diaminobenzidine (DAB) substrate-chromogen for 8 min, washed with dH 2 O, incubated with DAB enhancer (Innovex Biosciences, Richmond, CA) for 5 min, and washed with dH 2 O before counterstaining with hematoxylin. BrdU-positive hepatocytes were counted in five high-power ( ϫ 400) fields on each slide and the percentage of the BrdU-positive cells in total hepatocytes was determined after counting the number of hepatocytes in the same field. For detecting the HA-tagged I B, mouse monoclonal anti-HA antibody (5 l/ml, clone 12CA5; Boehringer Mannheim, Indianapolis, IN) was used as the primary antibody, and sections were stained as described above except for deleting the 4 N HCl incubation. Mitotic figures were also counted in the H&E-stained slides in the same way and expressed as a percentage of total hepatocytes.
In situ detection of apoptosis. Formalin-fixed and paraffin-embedded liver sections (5 m) were deparaffinized in xylene and rehydrated through graded ethanols. The TUNEL assay was performed using the In Situ Cell Death Detection Kit, AP (Boehringer Mannheim). DNA ends were tagged in situ with dUTP using terminal deoxynucleotidyl transferase by incubating sections in a humidified chamber for 60 min at 37 Њ C. Apoptotic cells were then detected with antifluorescein antibody conjugated with alkaline phosphatase (AP) for 30 min at 37 Њ C. Slides were incubated with NBT/BCIP (Boehringer Mannheim) for 10 min at 25 o C to visualize AP-positive cells, and then counterstained with hematoxylin. AP-positive cells were counted in five high-power fields on each slide and their percentage of total hepatocytes was determined.
Liver function tests. Blood samples were collected from each animal by aortic puncture before killing. Serum was stored at Ϫ 80 Њ C until measurement of alanine aminotransferase (ALT), bilirubin, and ammonia by automatic analysis by the UNC Division of Laboratory Animal Medicine.
RNA isolation and RT-PCR. Total RNA from liver was isolated by ultracentrifugation through a CsCl cushion (29) . For RT-PCR, 1 g of total liver RNA was reverse-transcribed using polyT oligonucleotide and MMLV reverse transcriptase (Perkin-Elmer/Applied Biosystems, Foster City, CA) in 25 l. Rat TNF-␣ was amplified using primers TNF5Ј (5Ј-CAC CAT GAG CAC GGA AAG CA-3Ј) and TNF3Ј (5Ј-GCA ATG ACT CCA AAG TAG ACC-3Ј) (1 M each) in a 50-l PCR reaction containing 1.5 mM MgCl 2 , 25 mM KCl, 10 mM Tris pH 9.2, and 1 l deoxynucleotides (1 mM each) using 5 l cDNA template. Dilutions of cDNA were amplified for 25, 28, 30, 33, and 35 cycles at 94ЊC for 30 s, 55ЊC for 30 s, and 72ЊC for 30 s to define optimal conditions for linearity to permit semiquantitative analysis of signal strength. The amplified PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining.
Results
Assessment of a recombinant adenovirus expressing NFB superrepressor.
A superrepressor I〉 contains serine-to-alanine mutations in residues 32 and 36, which inhibit its phosphorylation and proteosome-mediated degradation (12, 19, 20) . We packaged an HA-tagged version of this B S32A/S36A driven by the CMV promoter enhancer into the replication-deficient adenovirus Ad5 (Ad5IB) (23, 30) . Rat-1 fibroblasts were infected with this Ad5IB adenovirus at a different moi, and then whole cell extracts were prepared for Western blot analysis. Using an anti-IB␣ antibody, the HA-tagged IB was identified by its slower mobility compared with the endogenous I〉 by Western blotting, documenting the delivery of this cDNA by the adenoviral vectors (Fig. 1 A) . The effectiveness of this Ad5IB in blocking induction of NF〉 was assessed by prior infection with Ad5I〉 and then 24 h later treating the Rat-1 cells with TNF-␣ (50 ng/ml) for 1 h. Nuclear extracts were used in electrophoretic mobility shift assays to demonstrate the induction of NFB DNA binding activity. Inhibition of NFB DNA binding activity was demonstrated with Ad5IB, but not the control adenovirus Ad5LacZ (Fig. 1 B) . Specificity of the NFB DNA binding interaction was demonstrated by competition with 100-fold excess cold oligonucleotide (Fig. 1 B) . The effect of the Ad5IB adenovirus on NFB functional activity was assessed in a reporter gene assay in which the NFB-Luc plasmid was transfected into Rat-1 fibroblast after infection with Ad5IB or the controlled adenovirus Ad5LacZ. Using either p65 or TNF-␣ as an inducer of NFB transcriptional activity, prior infection with Ad5IB decreased both the control and the induced levels of the reported gene (Fig. 1, C  and D) . The residual stimulation of NF〉 after Ad5IB infection probably reflects the cells that were not infected by the adenovirus. Thus, Ad5IB delivered a functional IB superrepressor that inhibited NFB DNA binding and transcriptional activity in cultured cells. The control adenovirus Ad5LacZ had no effect on basal and induced levels of NFB transcriptional activity (Fig. 1, C and D) , even though ‫ف‬ 90% of cells were infected with Ad5LacZ at an moi of 1:50, as confirmed by ␤-galactosidase staining (data not shown).
In vivo infection with Ad5IB. Rats were injected in their tail veins with 10 10 pfu of Ad5IB and killed 24 h later. Western blotting using anti-IB antibody demonstrated high expression of the IB␣ S32A/S36A in the liver with lower levels detected in the spleen (Fig. 2 A) . After PH, rats infected with the control Ad5LacZ demonstrated a small increase in expression of IB␣ after 2 h and persisting for 24 h, as previously reported during liver regeneration (31) . On the other hand, Ad5IkB infection produced high levels of IB at 0 h and for 12 h after PH with some decreased expression by 24 h after PH (Fig. 2 B) . Immunohistochemistry using anti-HA antibody directed against the HA-tagged B demonstrated that ‫ف‬ 90% cells were expressing the NFB superrepressor at 24 h after PH with localization in both the cytoplasm and nucleus (Fig.   Figure 1 . Expression of IB␣ S32A/S36A inhibits NFB activity in Rat-1 fibroblasts. Extracts were generated from Rat-1 fibroblasts 24 h after infection with Ad5IB or Ad5LacZ, as described in Methods. (A) IB␣ was detected in whole cell extracts by Western blotting using anti-IB antibody. The HA-tagged IB␣ was identified by its lower mobility compared with the endogenous IB␣. (B) NFB DNA binding activity was assessed by electrophoretic mobility shift assay using an NFB binding site as probe with nuclear extracts prepared after a 1-h incubation with vehicle ( lanes 2-4) or TNF-␣ (lanes 5-7) . Infection with Ad5I〉 (lanes 3 and 6) or Ad5LacZ (lanes 4 and 7) was at an moi of 50:1. (C and D) A reporter gene assay was performed using NFBLuc. NFB activity was induced by either a 5-h incubation with TNF-␣ (C) or a cotransfection with a p65 expression plasmid (D). Infection with Ad5IB decreased both the basal and induced levels of the reporter gene.
D).
As discussed below, cells undergoing both mitosis or apoptosis expressed the HA tag. As a control, no expression of HA was detected in the Ad5LacZ-infected cells (Fig. 2 C) .
Electrophoretic mobility shift assays demonstrated the early induction of NFB binding activity after PH in the rats infected with the control Ad5LacZ (Fig. 2 E) , as previously described during liver regeneration in control rats (6, 8) . The constituents of the NFB binding activity were demonstrated by super-shift of the p50 and p65 subunits (data not shown). On the other hand, infection with Ad5IB before PH resulted in a decrease in the induction of NFB binding activity, consistent with effective delivery and expression of the IB superrepressor.
The IB superrepressor induces apoptosis during liver generation. Histological examination of uninfected, Ad5LacZ-infected and Ad5IB-infected rat livers after PH revealed key differences. At time 0, the Ad5LacZ and Ad5IB livers showed subtle cellular changes with occasional apoptotic cells (Fig. 3 , B and C compared with A). However, at 24 h after PH, the Ad5IB-infected livers demonstrated a marked increase in the number of apoptotic cells (Fig. 3 F) , as quantified in Fig. 3 J (middle). Although adenoviral infection alone produced limited apoptosis (Fig. 3 J, left) , the full effect required both Ad5IB and PH (Fig. 3 J, middle) . The in situ TUNEL assay was used as an independent measure of apoptotic cells (Fig. 3,  G-I) . At 24 h after PH, the percentages of apoptotic cells were ‫ف‬ 1% in the uninfected livers, 4% in the Ad5LacZ-infected livers, and 24% in the Ad5IB-infected livers (TUNEL positive cells/hepatocytes) (Fig. 3 J, right) . Thus, blocking of NFB induction by the IB superrepressor is associated with a strong stimulus to apoptosis of hepatocytes after PH.
Since TNF-␣ has been implicated as a potential comitogen Figure 2 . Expression of IB␣ S32A/S36A in rats in vivo. (A) IB␣ protein expression in rats at 24 h after injection of 10 10 AdIB was assessed by Western blotting using anti-IB antibody in the indicated tissue extracts. High expression of the IB␣ S32A/S36A in the liver was observed with lower levels detected in the spleen. (B) IB␣ protein expression in the liver was assessed by Western blotting using IB antibody at the indicated times after PH in rats 24 h after infection with Ad5IB (top) or Ad5LacZ (bottom). (C and D) Immunostaining for the HA-tagged IB␣ S32A/S36A was performed in the liver from rats infected with Ad5IB or Ad5LacZ using anti-HA antibody at 24 h after PH. Approximately 90% of hepatocytes were expressing the HA-tagged IB␣ S32A/S36A (D). The liver treated with Ad5LacZ had no expression (C) (ϫ400). (E) NFB DNA binding activity in the liver after PH was assessed by electrophoretic mobility shift assay using whole liver nuclear extracts prepared from Ad5LacZ-infected or IB-infected rats at 0 or 0.5 h after PH. Infection with Ad5IB abolished the activation of NFB binding activity after PH. For comparison, extracts from untreated or TNF-␣-treated NIH3T3 extracts are shown. Uninfected (A, D, and G) , Ad5LacZ-infected (B, E, and H), and Ad5IB-infected (C, F, and I) livers were stained with H&E at 0 (A-C) and 24 h (D-F) after PH (ϫ400) or underwent in situ TUNEL assay to detect apoptotic cells (G-I) (ϫ200). Ad5LacZ-infected (B) and Ad5IB-infected (C) liver showed subtle changes with occasional apoptosis. At 24 h after PH, the Ad5IB caused a dramatic increase in apoptotic cells (F and I). (J) Percentages of apoptotic cells among total hepatocytes were determined by counting apoptotic cells in the H&E staining (left and middle) or by TUNEL staining (right) as described in Methods. As an additional control, rats that did not undergo PH (24-0 h PH) at the identical time point after intravenous injection. (K) TNF-␣ mRNA expression in the liver after PH was assessed by RT-PCR of whole liver RNA prepared by uninfected, Ad5LacZ-infected, and Ad5IB-infected rats after PH, as described in Methods. The presence of adenoviral infection either by Ad5LacZ or Ad5IB led to induced levels of TNF-␣ mRNA before PH, but did not block TNF-␣ mRNA.
during liver regeneration, we wished to assess its expression in uninfected and infected livers after PH. As previously reported (32), TNF-␣ mRNA levels are induced by PH in the uninfected control animals (Fig. 3 K) . Adenoviral infection with either Ad5LacZ or Ad5IB led to induced levels of TNF-␣ before PH (Fig. 3 K) . These TNF-␣ levels were maintained after PH. Thus, the IB superrepressor did not inhibit TNF-␣ expression.
Inhibition of hepatocyte proliferation by IB superrepressor. DNA synthesis after PH was assessed by BrdU incorporation in uninfected, Ad5LacZ-infected, or Ad5IB-infected livers (Fig. 4, A-C) . Both the Ad5LacZ and Ad5IB infections resulted in an increase in the fraction of hepatocytes in S phase even before PH (Fig. 4 D) . At 24 and 48 h after PH, DNA synthesis, detected as percentage of BrdU-positive hepatocytes, increased in similar magnitude in the noninfected, Ad5IB-infected, and Ad5LacZ-infected livers (Fig. 4 D) . Thus, neither viral infection itself nor expression of the IB superrepressor inhibited DNA synthesis in hepatocytes during liver regeneration after PH. The effect on hepatocyte mitosis was assessed by quantifying the mitotic index after PH (Fig. 4 E, right) or without PH as an additional control (Fig. 4 E, left) . Ad5LacZ- infected livers had an increased mitotic index at 12 h after PH compared with the uninfected livers, and the mitotic index was equally increased at 24 and 48 h after PH, reflecting the elevated fraction of hepatocytes in S phase. In contrast, expression of the I B was associated with a marked reduction in the mitotic index at both 24 and 48 h. These results are consistent with expression of the I B superrepressor either inhibiting transition of hepatocytes through G2 during liver regeneration after PH or leading to the massive apoptosis of cells located in late S or G2 phases. Either event would explain the observed reduction of the fraction of hepatocytes in mitosis.
The effect of Ad5I B on liver function during liver regeneration. The extent of necrosis to hepatocytes was assessed by measuring the liver-specific enzyme ALT in the serum of the rats after PH. As shown in Fig. 5 A , there was only a slight increase in serum ALT in the Ad5I B-infected animals compared with the uninfected and Ad5LacZ-infected rats, suggesting that little leakage of this enzyme had occurred. However, hepatic function was compromised by apoptotic loss of hepatocytes, as indicated by a twofold increase in total bilirubin in the Ad5I B-treated rats compared with the Ad5LacZ-treated rats (Fig. 5 B ) . Furthermore, incipient liver failure in the (Fig. 3) . Expression of IB␣ S32A/S36A markedly inhibited the mitotic index at both 24 and 48 h. As an additional control, rats that did not undergo PH (0PH) were compared with rats that underwent PH at the identical time point (24 h).
Ad5IB-infected animals was indicated by the increased ammonia level compared with the uninfected and Ad5LacZ-infected animals, which were indistinguishable after PH (Fig. 5  C) . Thus, the pathophysiological sequelae of expression of the IB superrepressor resulted in jaundice, as documented by increased total bilirubin, and liver dysfunction as documented by ammonia, both possibly the result of massive cell loss from apoptosis, although more subtle metabolic changes in surviving cells cannot be ruled out. The lack of an increase in ALT reflects the predominant mechanism of cell death, i.e., apoptosis, and not necrosis.
Discussion
After PH, there is a rapid transient induction of DNA binding by NFB (6) (7) (8) 10) . The NFB binding peaks at 1 h after PH and subsequently declines. The NFB consists of p50/p65 heterodimers, p50 homodimers, and PHF, a complex of p50 and p35 (a truncated p65) (6, 10, 21) . The physiological consequences of this induction of NFB after PH are unknown. It might be a nonspecific response to the physiological stress or PH, it might be required for normal cellular proliferation, or it might fulfill other unknown functions in hepatic regeneration.
We efficiently delivered to the liver a recombinant adenovirus expressing the IB superrepressor, which has been validated in a variety of cultured cells in transfection experiments and now through viral delivery. After PH, infection with Ad5IB, but not a control adenovirus, resulted in the massive induction of apoptosis as demonstrated by histological staining and TUNEL analysis. In addition, infection with AD5IB, but not Ad5LacZ, markedly decreased the mitotic index after PH. These two phenomena, increased apoptosis and failure to progress through the cell cycle, were associated with liver dysfunction, as demonstrated by elevated serum bilirubin and ammonia levels.
The requirement for IL-6 and TNF-␣ in normal hepatic regeneration after PH has been established by the use of IL-6 and TNF receptor I (TNFRI) knockout mice (1, 9, 33) . PH in the IL-6 knockout mice resulted in liver necrosis and liver failure with G1 phase abnormalities including absence of STAT3 activation (9) . PH in the TNFR1 knockout mice resulted in decreased DNA synthesis, delayed restoration of liver mass, and increased mortality, with an absence of STAT3 and NF〉 activation (33) . In both knockout mice, normal hepatic regeneration was restored by the administration of exogenous IL-6 (9, 33), suggesting that TNF-␣ binds to the TNFR1 of Kupffer cells, inducing secretion of IL-6 (1). The IL-6 then binds to its receptor on hepatocytes, leading to the activation of STAT3.
Similar studies could not be performed to assess the role of NFB in hepatic regeneration because NFB p65 knockout mice are embryologically lethal (21). As an alternative approach, we took advantage of the recombinant adenovirus as a gene delivery system to express the IB superrepressor in the adult rat liver. Adenovirus has been used extensively to efficiently deliver genes specifically to the liver (34-37) in a variety of animals. The adenoviral vector gene delivery leads to short-term expression of genes in hepatocytes (35, 37, 38) . In a previous study, an adenoviral vector delivered p53 to the liver, and its expression had no effect on hepatic regeneration or hepatocyte function (35) . However, the control experiments in a recent study (39) and our study (Fig. 4) demonstrate that the adenovirus vectors alone induce DNA synthesis in 10% of hepatocytes.
Toxicity of the viral proteins is of concern with these first generation adenoviral vectors, including the induction of apoptosis and immune responses (40, 41). In our study, two different control groups were consistently used: non-viral-infected and control AdLacZ-infected animals. The dose of adenovirus was optimized in pilot experiments at 10 10 pfu per injection. Using these control groups in short-term experiments, we were able to minimize the adenoviral effect and differentiate it from the specific IB effect. At 24 h after PH, the number of apoptoic hepatocytes was 1% in uninfected livers, 4% in Ad5LacZ-infected livers, and 24% in Ad5IB-infected livers (Fig. 3) . Thus, in our study and in previous studies (35, 42, 43) , the adenoviral vector is an efficient method to deliver genes of interest to assess their transient effect in the liver in vivo.
Although the factors responsible for induction of NFB during liver regeneration are still under investigation, the most likely candidate is TNF-␣. TNF-␣ expression is induced during liver regeneration after PH (44) . Neutralizing antibodies to TNF-␣ inhibit hepatocyte DNA synthesis during liver regeneration after PH (45) . TNF-␣ is a potent inducer of NFB in a variety of cell lines and will induce NFB in vivo in the liver (8); and NF〉 is not activated in TNFRI knockout mice (33) . Finally, TNF-␣ will stimulate DNA synthesis in primary hepatocyte cultures (45) . In our study, pretreatment with either Ad5IB or Ad5LacZ did not block TNF-␣ mRNA levels as documented by RT-PCR, and pretreatment with Ad5LacZ did not block NFB.
TNF-␣, ionizing radiation, and daunorubicin induce both NFB and apoptosis. The relationship between NF〉 and apoptosis was elucidated recently by studies demonstrating that inhibition of NFB, either by the IB superrepressor (19, 20) or in p65 knockout cells (46), results in increased apoptosis by these agents. TNF-␣ mediates stimulation of NFB as well as JNK through the TNF receptor-associated protein TRAF2 (TNF receptor-associated factor 2) (47-49). The signal for apoptosis is mediated by the TNF receptor-associated protein TRADD (TNF receptor-associated death domain) which in turn interacts with FADD (Fas-associated death domain protein) leading to activation of proapoptotic proteases (capases) (50, 51) . The mechanism by which NF〉 blocks apoptosis is unknown. In our study, inhibition of NFB by the IB superrepressor revealed an underlying apoptotic stimulus occurring during liver regeneration after PH. As discussed above, a possible explanation is that the enhanced TNF-␣ expression required for normal liver regeneration activates both apoptotic and NFB signals in hepatocytes. The antiapoptotic activity of NFB prevents apoptosis in hepatocytes during normal liver regeneration after PH. Thus, the IB superrepressor unmasks this apoptotic stimuli, demonstrating a critical role for hepatocyte NFB in normal liver regeneration.
We have less insight into the mechanism by which inhibition of NFB results in the decreased mitotic index during liver regeneration at 24 and 48 h after PH. An association of NFB binding activity with the G0 to G1 transition has been reported (11) but a relationship to the G2 phase of the cell cycle has not been demonstrated. Since DNA synthesis as documented by BrdU labeling is normal despite the inhibition of NFB, there does not appear to be a block in the G1 phase. Alternatively, inhibition of NFB may have shifted the mitotic index to a time point that was not measured by our study.
The timing of apoptosis after PH, the entry of the expected fraction of cells into the S phase, and the severity of subsequent inhibition of mitosis suggest that apoptosis is occurring during the S and/or G2 phase in the presence of the I〉 superrepressor. On the other hand, if apoptosis occurred predominantly in the G1 phase or the G1/S checkpoint, the apoptosis would occur earlier after PH and the number of S phase cells would be reduced compared with controls. Previous studies have demonstrated that during cell cycle transit, apoptosis may be triggered in cells delayed at the G1/S checkpoint, the G2/M checkpoint, as well as during S phase or M phase when DNA synthesis or spindle formation is perturbed in major ways (44, 52, 53) . We propose that inhibition of NF〉 results in apoptosis (and not cell-cycle arrest) in the S or G2 phases of cell cycle progression during liver regeneration. A product of an NFBresponsive gene may be required to block apoptosis and/or enable cell cycle progression.
